Terms: = Brain cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
144 results:
1. Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
Cao Q; Hajosch A; Kast RE; Loehmann C; Hlavac M; Fischer-Posovszky P; Strobel H; Westhoff MA; Siegelin MD; Wirtz CR; Halatsch ME; Karpel-Massler G
Br J Cancer; 2024 May; 130(8):1365-1376. PubMed ID: 38396172
[TBL] [Abstract] [Full Text] [Related]
2. bcl2A1 is associated with tumor-associated macrophages and unfavorable prognosis in human gliomas.
Gao L; Ye Z; Peng S; Lei P; Song P; Li Z; Zhou L; Hua Q; Cheng L; Wei H; Liu J; Cai Q
Aging (Albany NY); 2023 Oct; 15(20):11611-11638. PubMed ID: 37889551
[TBL] [Abstract] [Full Text] [Related]
3. A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.
Liu W; Fu Y; Wang M; Zhao J; Chen J; Wang Y; Qin H
Sci Rep; 2023 Oct; 13(1):17153. PubMed ID: 37821528
[TBL] [Abstract] [Full Text] [Related]
4. Chemical modification of curcumin increases its potency against hypopharyngeal carcinoma.
Zhang L; Cheng L; Chen Z; Fang Y; Li C; Chen M; He P; Wu H; Wu J; Chen J
J Drug Target; 2023 Sep; 31(8):867-877. PubMed ID: 37577780
[TBL] [Abstract] [Full Text] [Related]
5. [Lactate-induced up-regulation of PLEKHA4 promotes proliferation and apoptosis of human glioma cells].
Ye J; Xu W; Xi B; Wang N; Chen T
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1071-1080. PubMed ID: 37488789
[TBL] [Abstract] [Full Text] [Related]
6. Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Tsakonas G; Tadigotla V; Chakrabortty SK; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Lung Cancer; 2023 Aug; 182():107292. PubMed ID: 37423059
[TBL] [Abstract] [Full Text] [Related]
7. Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series.
van Schie P; Rijksen BLT; Bot M; Wiersma T; Merckel LG; Brandsma D; Compter A; de Witt Hamer PC; Post R; Borst GR
J Neurooncol; 2023 Jun; 163(2):345-354. PubMed ID: 37266846
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of glioblastoma proliferation, invasion, and migration by Urolithin B through inducing G0/G1 arrest and targeting MMP-2/-9 expression and activity.
Eidizade F; Soukhtanloo M; Zhiani R; Mehrzad J; Mirzavi F
Biofactors; 2023 Mar; 49(2):379-389. PubMed ID: 36310375
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological Characterization of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
Woo HY; Chae SW; DO SI; Na K
Anticancer Res; 2022 Nov; 42(11):5601-5608. PubMed ID: 36288864
[TBL] [Abstract] [Full Text] [Related]
10. Diterpenoid DGA induces apoptosis via endoplasmic reticulum stress caused by changes in glycosphingolipid composition and inhibition of STAT3 in glioma cells.
Kong T; He Z; Wang S; Jiang C; Zhu F; Gao J; Li L; Wang Y; Xie Q; Li Y
Biochem Pharmacol; 2022 Nov; 205():115254. PubMed ID: 36210604
[TBL] [Abstract] [Full Text] [Related]
11. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract] [Full Text] [Related]
12. Knockdown of Girdin Induced Apoptosis of Glioblastoma Cells via the Mitochondrion Signaling Pathway.
Liu X; Zhang H; Zhao Y; Ma Y
Neuroscience; 2022 Sep; 500():95-105. PubMed ID: 35952993
[TBL] [Abstract] [Full Text] [Related]
13. SOCS5 contributes to temozolomide resistance in glioblastoma by regulating bcl-2-mediated autophagy.
Yu J; Han L; Yang F; Zhao M; Zhou H; Hu L
Bioengineered; 2022 Jun; 13(6):14125-14137. PubMed ID: 35730472
[TBL] [Abstract] [Full Text] [Related]
14. Syringic Acid Suppressed Proliferation, Invasion, and Migration via Inhibition of Matrix Metalloproteinases Expression on Glioblastoma Cells by Promoting Apoptosis.
Li D; Luo D; Hu S; Zhao H; Peng B
Curr Pharm Biotechnol; 2023; 24(2):310-316. PubMed ID: 35570553
[TBL] [Abstract] [Full Text] [Related]
15. Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics.
Koessinger AL; Cloix C; Koessinger D; Heiland DH; Bock FJ; Strathdee K; Kinch K; Martínez-Escardó L; Paul NR; Nixon C; Malviya G; Jackson MR; Campbell KJ; Stevenson K; Davis S; Elmasry Y; Ahmed A; O'Prey J; Ichim G; Schnell O; Stewart W; Blyth K; Ryan KM; Chalmers AJ; Norman JC; Tait SWG
Cell Death Differ; 2022 Oct; 29(10):2089-2104. PubMed ID: 35473984
[TBL] [Abstract] [Full Text] [Related]
16. Controlled microwave-assisted reactions: A facile synthesis of polyfunctionally substituted phthalazines as dual EGFR and PI3K inhibitors in CNS SNB-75 cell line.
Hassan Nazmy M; Ahmed Mekheimer R; Shoman ME; Abo-Elsebaa M; Abd-Elmonem M; Usef Sadek K
Bioorg Chem; 2022 May; 122():105740. PubMed ID: 35298961
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological Features Associated with Microsatellite Instability/Mismatch Repair Deficiency in Uterine Carcinosarcoma: A Quantitative Systematic Review.
Travaglino A; Raffone A; Santoro A; Raimondo D; Orsini B; Casadio P; Zullo F; Seracchioli R; Zannoni GF; Insabato L; Mollo A
Pathobiology; 2022; 89(4):198-204. PubMed ID: 35231921
[TBL] [Abstract] [Full Text] [Related]
18. CD44 loss of function sensitizes AML cells to the bcl-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues.
Yu X; Munoz-Sagredo L; Streule K; Muschong P; Bayer E; Walter RJ; Gutjahr JC; Greil R; Concha ML; Müller-Tidow C; Hartmann TN; Orian-Rousseau V
Blood; 2021 Sep; 138(12):1067-1080. PubMed ID: 34115113
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of radiomic feature aggregation methods for patients with multiple tumors.
Chang E; Joel MZ; Chang HY; Du J; Khanna O; Omuro A; Chiang V; Aneja S
Sci Rep; 2021 May; 11(1):9758. PubMed ID: 33963236
[TBL] [Abstract] [Full Text] [Related]
20. TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells.
Scuderi SA; Lanza M; Casili G; Esposito F; Colarossi C; Giuffrida D; Irene P; Cuzzocrea S; Esposito E; Campolo M
Oncol Res; 2021 Sep; 28(7):779-790. PubMed ID: 33741083
[TBL] [Abstract] [Full Text] [Related]
[Next]
